US › Healthcare

Aclarion Inc (ACON)

US · Healthcare · Health Information Services

$2.38+0.85%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$21,140
Revenue YoY
+11.3%
Net profit
$-2.9M
Profit YoY
-40.1%
EPS
$-1.34
EPS estimate
$-1.55
Net margin
-13,498.5%

EPS came in at -1.34 against a street estimate of -1.55 — a beat of 13.5%.

Key statistics

Market cap
$5.5M
Forward P/E
0.0
P/B
0.28
Book value
$8.04
EPS (TTM)
$-5.63
52-week high
$12.03
52-week low
$1.95
50-day MA
$2.91
200-day MA
$4.19
Beta
1.22

Analyst view

Analysts rate Aclarion Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.50.

Shareholding

Insiders
26.20%
Institutions
4.35%

Largest institutional holders

FundStake
Advisor Group Holdings, Inc.1.42%
Geode Capital Management, LLC1.27%
CapTrust Financial Advisors0.59%
Bank of Montreal0.41%
BMO Capital Markets Corp.0.41%
UBS Group AG0.39%
Vanguard Capital Management, LLC0.28%
Dauntless Investment Group, LLC0.22%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aclarion Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.